- Home
- CMPX vs CLB Comparison
CMPX vs CLB Comparison
Compare CMPX & CLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- CLB
- Stock Information
- Founded
- CMPX 2014
- CLB 1936
- Country
- CMPX United States
- CLB United States
- Employees
- CMPX N/A
- CLB N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- CLB
- Sector
- CMPX Health Care
- CLB
- Exchange
- CMPX Nasdaq
- CLB Nasdaq
- Market Cap
- CMPX 576.5M
- CLB 482.5M
- IPO Year
- CMPX N/A
- CLB 1995
- Fundamental
- Price
- CMPX $3.65
- CLB $12.04
- Analyst Decision
- CMPX Strong Buy
- CLB Hold
- Analyst Count
- CMPX 7
- CLB 2
- Target Price
- CMPX $14.71
- CLB $12.50
- AVG Volume (30 Days)
- CMPX 1.7M
- CLB 496.6K
- Earning Date
- CMPX 11-11-2025
- CLB 10-22-2025
- Dividend Yield
- CMPX N/A
- CLB 0.34%
- EPS Growth
- CMPX N/A
- CLB 23.99
- EPS
- CMPX N/A
- CLB 0.62
- Revenue
- CMPX N/A
- CLB $517,378,000.00
- Revenue This Year
- CMPX N/A
- CLB N/A
- Revenue Next Year
- CMPX N/A
- CLB $2.23
- P/E Ratio
- CMPX N/A
- CLB $19.22
- Revenue Growth
- CMPX N/A
- CLB 0.70
- 52 Week Low
- CMPX $1.27
- CLB $9.72
- 52 Week High
- CMPX $4.08
- CLB $21.83
- Technical
- Relative Strength Index (RSI)
- CMPX 56.88
- CLB 49.28
- Support Level
- CMPX $3.31
- CLB $11.98
- Resistance Level
- CMPX $3.80
- CLB $12.79
- Average True Range (ATR)
- CMPX 0.24
- CLB 0.50
- MACD
- CMPX -0.01
- CLB -0.08
- Stochastic Oscillator
- CMPX 70.51
- CLB 18.84
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About CLB Core Laboratories Inc.
Core Laboratories Inc provides reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.